Abstract
Materials and Methods

Cell Culture Maintenance
C2C12 myoblasts were derived from mouse hind limb [16] [17] , and are commonly used for skeletal muscle cell culture experiments. They are ideal for studying myoblast fusion to form myotubes, and acetylcholine receptor (AChR) clustering. For normal maintenance of C2C12 cell culture, myoblasts were first plated in growth medium (GM) on 10 cm plates at approximately 20% confluence. GM consists of Dulbecco's modified Eagle's medium (DMEM) plus 20% fetal bovine serum, 0.5% chick embryo extract and 100 U/ml penicillin. Fresh GM was added daily, and myoblast cultures were split into new plates at approximately 60% confluence. For formation of myotubes, myoblasts were plated in GM on 22 × 22 mm cover slips that had been flamed in 200-proof ethanol and placed in 6-well plates. Fresh GM was added daily. After 48 hours in GM, myoblast cultures typically reached 80% confluence, and cultures were then switched to differentiation medium (DM). DM consists of DMEM plus 2% horse serum and 100 U/ml penicillin. Fresh DM was added daily as myoblasts fused to form myotubes, and cultures were maintained for 72 hours in DM. All cultures were exposed to 10 ng/ml agrin (R & D Systems) for the last 16 hours of 72 hours in DM to induce AChR clustering. Some cultures were exposed to 10 nM -10 μM bisphenol A (BPA; Sigma-Aldrich) or 10 nM -100 μM di-(2-ethylhexyl) phthalate (DEHP; Sigma-Aldrich) for the last 48 hours of 72 hours in DM. BPA stock solution was created by dissolving BPA in dimethyl sulfoxide (DMSO; Sigma-Aldrich), while DEHP was purchased as a stock solution in DMSO. Serial dilutions of stock solutions with DM achieved the treatment concentrations. The highest concentration of DMSO the cells were exposed to has previously been shown to have no effect on myoblast proliferation or fusion into myotubes [28] . The incubator was maintained at 37˚C under 8% carbon dioxide and 100% humidity.
Acetylcholine Receptor Clustering Assay
AChRs were labeled by the binding of α-bungarotoxin conjugated to tetramethylrhodamine (Molecular Probes) [29] . Cultures were incubated in the toxin-containing medium for 30 minutes at 37˚C to label AChRs after 72 hours in DM. The cover slips were rinsed three times with room temperature phosphate buffered saline (PBS), fixed for 10 minutes with 2% paraformaldehyde in PBS, rinsed three times with PBS, dehydrated in cold methanol for 5 minutes at −20˚C, and mounted on microscope slides in Vectashield Mounting Medium for Fluorescence (Vector Laboratories). For some experiments the mounting medium contained 4'6-diamidino-2-phenylindole (DAPI) to visualize nuclei. AChR clusters were visualized with an IX70 Olympus inverted microscope under the 20× objective (yielding a total magnification of 200×), and fluorescent images were captured as high-resolution JPG files with an Olympus camera with Magnafire digital imaging software. Bright clusters of AChRs were observed on all aspects of myotubes in fluorescent images. AChR clusters were counted from 25 images captured as JPG files from each cover slip. One cover slip was analyzed for each treatment group or control in each of five replicate experiments. AChR clusters were counted by an individual blind to treatment group. These data were utilized to assay agrin-induced AChR clustering in untreated cultures, or after exposure to 10 nM -10 μM BPA or 10 nM -100 μM DEHP for the last 48 hours of 72 hours in DM. Comparisons of untreated cultures with cultures exposed to BPA or DEHP were analyzed by Student's t-test to determine statistically different results at p < 0.05. Representative images were assembled into Figure 3 using Adobe Photoshop.
Myotube Formation Index
Cell cultures were visualized with an IX70 Olympus inverted microscope under the 20× objective (yielding a total magnification of 200×), and representative phase contrast and DAPI images were captured as high-resolution JPG files with an Olympus camera with Magnafire digital imaging software. These JPG files were utilized to quantify myotube formation by modifying a myoblast fusion index paradigm [30] into a myotube formation index used in our laboratory [27] [31] [32] . In brief, the number of nuclei in myoblasts (defined as cells with one or two nuclei) and myotubes (defined as cells with three or more nuclei) were counted after 72 hours in DM. Only nuclei obviously in myoblasts were counted as such. All nuclei for which a designation was difficult were grouped with the nuclei in myotubes. This method biased the data toward a greater percentage of nuclei in myotubes. A total of ten pairs of images (phase contrast and DAPI) were analyzed for untreated cultures, five pairs of images for cultures exposed to 10 μM BPA for the last 48 hours of 72 hours in DM, and five pairs of images for cultures exposed to 100 μM DEHP for the last 48 hours of 72 hours in DM. For each image, nuclei were determined to be either in a myoblast or myotube prior to counting. The myotube formation index was then calculated as nuclei in myoblasts divided by total nuclei in the image and reported in Table 1 as a percentage of nuclei in myoblasts.
Western Blots
To assay for protein levels of the myogenic regulatory factor myogenin, myotube cultures were divided into untreated cultures, those that had been exposed to 10 μM or 100 μM BPA for the last 48 hours of 72 hours in DM, and those that had been exposed to 100 μM or 1 mM DEHP for the last 48 hours of 72 hours in DM. Myotubecultures were rinsed twice with calcium-and magnesium-free PBS (CMF-PBS), scraped off in RIPA complete lysis buffer (containing PMSF, sodium orthovanadate, and protease inhibitors), agitated for 30 minutes on ice, and then centrifuged at 13,000 g for 2 minutes to create pellets containing insoluble materials such as organelles and extracellular matrix. The extracted supernatant was then frozen. At a later time samples were thawed, a BCA protein assay was performed to determine the concentration of protein in each sample, and samples were boiled for 5 minutes in sample buffer to reduce and denature proteins. Then samples were separated by electrophoresis on a 10% polyacrylamide gel (Bio-Rad) and transferred to a nitrocellulose membrane. The membranes were blocked with 5% milk in TBS-T, probed for 16 hours at 4˚C with a mouse monoclonal antibody to myoge- Table 1 . BPA or DEHP decrease myotube formation. The myotube formation index was calculated as nuclei in myoblasts divided by total nuclei and reported as a percentage of nuclei in myoblasts. The larger the percentage of nuclei remaining in myoblasts, the less myotube formation has proceeded. Myotube formation was decreased with exposure to 10 μM BPA or 100 μM DEHP for the last 48 hours of 72 hours in differentiation medium. nin (sc-12732; Santa Cruz Biotechnology) at 1:1000 in blocking solution, and then probed by a goat anti-mouse secondary antibody (92-32210; Li-Cor) at 1:10,000 in blocking solution for 30 minutes. The resultant western blot was then visualized with the Odyssey CLx, a near infrared imaging system. It uses solid state diode lasers to excite at 685 and 785 nm. For scanning, the western blot was placed on the glass surface of the odyssey and covered with a rubber mat. In the Li-Cor software a box was created to define the scanning area of the blot. The 700 and 800 channels were chosen and low quality image quality and 169 μm resolution was checked before "start scan" was pressed. As a loading control, all samples were also probed with a mouse monoclonal antibody to actin (sc-8432; Santa Cruz Biotechnology).
Results
The results reported here demonstrate that 10 μM BPA or 100 μM DEHP decreased the frequency of agrin-induced AChR clusters and myotube formation. Furthermore, BPA or DEHP reduced the amount of myogenin protein.
BPA or DEHP Decrease the Frequency of Agrin-Induced AChR Clusters
AChRs cluster spontaneously with a baseline frequency on C2C12 myotubes and this clustering is increased with agrin treatment [18] - [20] . C2C12 cell cultures were switched from GM to DM at 80% confluence, 10 ng/ml agrin was added for the last 16 hours in DM, and myotubes were examined for AChR clustering after 72 hours in DM. Some cultures were left untreated (control cultures), while others were exposed to 10 nM -10 μM BPA or 10 nM -100 μM DEHP for the last 48 hours of 72 hours in DM. For each experiment one cover slip was analyzed for each treatment group or control. AChR clusters were counted from 25 images captured as JPG files from each cover slip. Each experiment was replicated five times with similar results, with typical data sets reported ( Figure 1 and Figure 2 ). 10 μM BPA (Figure 1 and Figure 3 ) or 100 μM DEHP (Figure 2 and Figure 3 ) was sufficient to decrease the frequency of agrin-induced AChR clusters, with statistical significance at p < 0.05 using Student's t-test. Specifically 10 μM BPA decreased agrin-induced AChR clusters by 30%, while 100 μM DEHP decreased agrin-induced AChR clusters by 38%, in the data sets reported.
BPA or DEHP Decrease Myotube Formation
Myotube formation was quantified by modifying a myoblast fusion index paradigm [30] into a myotube formation index used in our laboratory [27] [31] [32] . In brief, the number of nuclei in myoblasts (defined as cells with one or two nuclei) and myotubes (defined as cells with three or more nuclei) were counted after 72 hours in DM. The myotube formation index was then calculated as nuclei in myoblasts divided by total nuclei in the image and reported as a percentage of nuclei in myoblasts ( Table 1) . The larger the percentage of nuclei remaining in myoblasts, the less myotube formation has proceeded. The percentage of nuclei in myoblasts more than doubled with exposure to 10 μM BPA or 100 μM DEHP.
BPA or DEHP Reduce Myogenin Protein
A decrease in the frequency of agrin-induced AChR clusters could have many causes. The myogenic regulatory factor myogenin activates genes for AChR subunits [24] [25] . This suggests that myogenic regulatory factors (Figure 4) , or 100 μM or 1 mM DEHP (Figure 5) , reduced the amount of myogenin protein. Specifically 10 μM or 100 μM BPA reduced myogenin to 77% of the amount in untreated cultures, while 100 μM DEHP reduced myogenin to 54% and 1 mM DEHP reduced myogenin to 28%, in the western blots reported. All values compared were a ratio of myogenin to actin and normalized to 1.00 for untreated cultures, as analyzed by the Li-Cor software.
Discussion
BPA and its metabolites have been detected in human urine, breast milk, saliva, serum, plasma, ovarian follicular fluid, and amniotic fluid [33] . Some of the earliest studies to investigate BPA were concerned with exposure from resin-based composites and sealants used in dentistry. Samples collected one hour after treatment with a dental sealant based on BPA yielded 90 -931 μg of BPA in the patient's saliva. In addition, the estrogenicity of BPA was demonstrated in a breast cancer cell culture system [34] . However, based on an analysis of several studies of BPA levels in food and drink, as well as human urine, it was estimated that more typically exposure to BPA ranges from about 0.001 to 0.1 μg/kg/day [35] . By the backward calculation approach based on urinary excretion, 95% confidence intervals for daily intake of BPA for high-exposure populations in Japan yielded 0.037 -0.064 μg/kg/day for males and 0.043 to 0.075 μg/kg/day for females [36] . Even a study of infants fed baby formula found a probable maximum daily intake of BPA of only 1.35 μg/kg/day, with the amount of BPA detected in various liquid infant formulas ranging from 2.27 ng/g to 10.2 ng/g [37] . In summary, it is likely that daily intake of BPA for most humans is less than 1 μg/kg/day [38] . For comparison, the United States Environmental Protection Agency reference dose for BPA is 50 μg/kg/day, the European Union temporary tolerable daily intake of BPA is 10 μg/kg/day [36] , and the provisional tolerable daily intake of BPA established by Health Canada is 25 μg/kg/day [37] . Because BPA is metabolized and eliminated in urine rather quickly, a number of studies have concluded that it is unlikely that humans, including infants and children, are at risk from the presence of BPA in consumer products [35] [36] . The human data differs from animal data suggesting that BPA is acutely toxic to aquatic organisms [38] and that low doses of BPA have estrogenic effects in laboratory animals [35] . Phthalates, including DEHP or its primary metabolite mono-2-ethylhexyl phthalate (MEHP), are commonly measured in urine, serum, or breast milk. When DEHP or MEHP was measured in the serum of cord blood of newborns, a correlation between higher phthalate concentrations and shorter pregnancy duration was found [39] . In a study conducted 1 -3 months postnatally, breast milk samples were collected from mothers and serum samples from their male infants. The breast milk contained several phthalates including MEHP with a median value of 11 μg/L and a range of 1.5 -1410 μg/L. The serum also contained several phthalates which correlated with hormonal deficiencies related to reproductive tract development, and suggested that human Leydig cell development and function might be vulnerable to perinatal exposure to phthalates [40] . In rats phthalates interfere with the androgen signaling pathway. Specifically, exposure of pregnant rats to phthalates decreases mRNA ex-pression of key steroidogenic enzymes in fetal rat Leydig cells, ultimately lowering testosterone levels. Mixtures of phthalates with one another and other anti-androgenic compounds has a dose dependent additive effect that increases abnormal male reproductive tract development in rats [41] [42] . An epidemiologic study found that certain phthalates, including DEHP, measured in prenatal urine of pregnant women, correlated with reduced anogenital distance in human male infants of three years of age or less. This was the first evidence of developmental effects in male infants exposed prenatally to phthalates. Reduced anogenital distance in response to prenatal phthalate exposure has been well documented in rats as a phthalate syndrome [43] [44] . Estimates of daily exposure to DEHP in humans vary, with one study suggesting a median exposure of 1.32 μg/kg/day and an exposure of 9.32 μg/kg/day at the 95th percentile [44] , and another study suggesting a range from 3 -30 μg/kg/day [45] . High levels of phthalates can modulate the murine immune response to a coallergen. In addition, correlations have now been shown for indicators of home phthalate exposure and incidence of asthma and allergies [46] . Even adult males are affected by phthalate exposure, with higher phthalate levels measured in the urine of men with lower sperm counts and reduced sperm motility [47] . Phthalate exposure in humans has been hypothesized to cause a human analog of the phthalate syndrome in rats, where urinary metabolites in pregnant rats correlate with an increased risk of anti-androgenic activity in male rat pups [48] . A testicular dysgenesis syndrome in humans has also been hypothesized to occur with sufficient phthalate exposure. Symptoms include cryptorchidism and hypospadias in newborn males and low sperm counts and testicular germ cell cancer in young male adults [49] .
Much of the early research with plastic additives like BPA or DEHP examined the effects on the development of the reproductive system. More recently the brain has been a target of BPA research. Specifically, BPA impaired spatial and passive avoidance memory in adult male mice, while reducing synaptic density and synaptic proteins in the hippocampus of adult and young male mice [50] [51] . In addition, BPA reduced spine synapses in the hippocampus of fetal monkeys but not juvenile monkeys [52] . Finally, BPA decreased motor behaviors and axonal growth of motor neurons in developing zebrafish [53] . We are unaware of any comparable studies with DEHP.
Very little research has examined the effects of BPA or DEHP on skeletal muscle development. Myotube formation and myogenin protein levels were decreased by DEHP in a study with C2C12 cells [54] . They reported that 1000 μg/ml DEHP increased the percentage of nuclei remaining as myoblasts by 1.84 fold, with more modest increases at lower concentrations of DEHP. This compares with our data that 100 μM (39 μg/ml) DEHP increased the percentage of nuclei in myoblasts 2.66 fold. They also reported that 1000 μg/ml DEHP decreased myogenin protein after three days in DM by about 25%. This compares with our data that 100 μM (39 μg/ml) DEHP decreased myogenin protein after three days in DM by about 50%. Differences in experimental protocol account for the variability in data obtained, but the results are the same. DEHP decreases myotube formation and myogenin protein levels in C2C12 cell culture. We are unaware of any comparable study with BPA other than our own data that BPA also decreases myotube formation and myogenin protein levels. This may be a general effect of plastic additives on skeletal muscle development.
Conclusion
Since BPA and DEHP interfere with myotube formation and subsequent neuromuscular synapse formation, they may pose a risk for skeletal muscle development in humans. The results reported here demonstrate that 10 μM BPA or 100 μM DEHP decreased the frequency of agrin-induced AChR clusters and myotube formation. Furthermore, BPA or DEHP reduced the amount of myogenin protein. This suggests that BPA and DEHP decrease AChR clustering by reducing myogenin, and that myogenic regulatory factors like myogenin are intricately linked to the development of the postsynaptic component of the neuromuscular synapse.
